Literature DB >> 18071701

Radiation dosimetry of N-([11C]methyl)benperidol as determined by whole-body PET imaging of primates.

Jo Ann V Antenor-Dorsey1, Richard Laforest, Stephen M Moerlein, Tom O Videen, Joel S Perlmutter.   

Abstract

PURPOSE: N-([(11)C]methyl)benperidol ([(11)C]NMB) can be used for positron emission tomography (PET) measurements of D(2)-like dopamine receptor binding in vivo. We report the absorbed radiation dosimetry of i.v.-administered (11)C-NMB, a critical step before applying this radioligand to imaging studies in humans.
MATERIALS AND METHODS: Whole-body PET imaging with a CTI/Siemens ECAT 953B scanner was done in a male and a female baboon. After i.v. injection of 444-1221 MBq of (11)C-NMB, sequential images taken from the head to the pelvis were collected for 3 h. Volumes of interest (VOIs) were identified that entirely encompassed small organs (whole brain, striatum, eyes, and myocardium). Large organs (liver, lungs, kidneys, lower large intestine, and urinary bladder) were sampled by drawing representative regions within the organ volume. Time-activity curves for each VOI were extracted from the PET, and organ residence times were calculated by analytical integration of a multi-exponential fit of the time-activity curves. Human radiation doses were estimated using OLINDA/EXM 1.0 and the standard human model.
RESULTS: Highest retention was observed in the blood and liver, each with total residence times of 1.5 min. The highest absorbed radiation doses were to the heart (10.5 μGy/MBq) [DOSAGE ERROR CORRECTED] and kidney (9.19 μGy/MBq), [DOSAGE ERROR CORRECTED] making these the critical organs for [(11)C]NMB. A heart absorption of 50 mGy would result from an injected dose of 4,762 MBq [(11)C]NMB.
CONCLUSIONS: Thus, this study suggests that up to 4,762 MBq of [(11)C]NMB can be safely administered to human subjects for PET studies. Total body dose and effective dose for [(11)C]NMB are 2.82 μGy/MBq [DOSAGE ERROR CORRECTED] and 3.7 mSv/kBq, respectively.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18071701      PMCID: PMC3017464          DOI: 10.1007/s00259-007-0644-6

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  23 in total

1.  Radiation dosimetry of [18F] (N-methyl)benperidol as determined by whole-body PET imaging of primates.

Authors:  S M Moerlein; J S Perlmutter; P D Cutler; M J Welch
Journal:  Nucl Med Biol       Date:  1997-05       Impact factor: 2.408

2.  Model-based scatter correction for fully 3D PET.

Authors:  J M Ollinger
Journal:  Phys Med Biol       Date:  1996-01       Impact factor: 3.609

3.  Striatal binding of the PET ligand 11C-raclopride is altered by drugs that modify synaptic dopamine levels.

Authors:  S L Dewey; G S Smith; J Logan; J D Brodie; J S Fowler; A P Wolf
Journal:  Synapse       Date:  1993-04       Impact factor: 2.562

4.  OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine.

Authors:  Michael G Stabin; Richard B Sparks; Eric Crowe
Journal:  J Nucl Med       Date:  2005-06       Impact factor: 10.057

5.  Distribution, excretion and metabolism of neuroleptics of the butyrophenone type. I. Excretion and metabolism of haloperidol and nine related butyrophenone-derivatives in the Wistar rat.

Authors:  W Soudijn; I Van Wijngaarden; F Allewijn
Journal:  Eur J Pharmacol       Date:  1967-01       Impact factor: 4.432

6.  64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors.

Authors:  C J Anderson; F Dehdashti; P D Cutler; S W Schwarz; R Laforest; L A Bass; J S Lewis; D W McCarthy
Journal:  J Nucl Med       Date:  2001-02       Impact factor: 10.057

7.  Decreased [18F]spiperone binding in putamen in idiopathic focal dystonia.

Authors:  J S Perlmutter; M K Stambuk; J Markham; K J Black; L McGee-Minnich; J Jankovic; S M Moerlein
Journal:  J Neurosci       Date:  1997-01-15       Impact factor: 6.167

8.  Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans.

Authors:  Patrizia Riccardi; Rui Li; Mohammad Sib Ansari; David Zald; Sohee Park; Benoit Dawant; Sharlet Anderson; Mikisha Doop; Neil Woodward; Evan Schoenberg; Dennis Schmidt; Ronald Baldwin; Robert Kessler
Journal:  Neuropsychopharmacology       Date:  2006-05       Impact factor: 7.853

9.  Cross-sectional growth standards for captive baboons: II. Organ weight by body weight.

Authors:  M C Mahaney; M M Leland; S Williams-Blangero; Y N Marinez
Journal:  J Med Primatol       Date:  1993 Sep-Oct       Impact factor: 0.667

10.  In vivo binding of 3H-N-methylspiperone to dopamine and serotonin receptors.

Authors:  J J Frost; A C Smith; M J Kuhar; R F Dannals; H N Wagner
Journal:  Life Sci       Date:  1987-03-09       Impact factor: 5.037

View more
  3 in total

1.  Absorbed radiation dosimetry of the D3-specific PET radioligand [18F]FluorTriopride estimated using rodent and nonhuman primate.

Authors:  Richard Laforest; Morvarid Karimi; Stephen M Moerlein; Jinbin Xu; Hubert P Flores; Christopher Bognar; Aixiao Li; Robert H Mach; Joel S Perlmutter; Zhude Tu
Journal:  Am J Nucl Med Mol Imaging       Date:  2016-11-30

2.  Radiation dosimetry and biodistribution in non-human primates of the sodium/iodide PET ligand [(18)F]-tetrafluoroborate.

Authors:  J M Marti-Climent; M Collantes; M Jauregui-Osoro; G Quincoces; E Prieto; I Bilbao; M Ecay; J A Richter; I Peñuelas
Journal:  EJNMMI Res       Date:  2015-12-03       Impact factor: 3.138

3.  Radiation dosimetry of [(18)F]VAT in nonhuman primates.

Authors:  Morvarid Karimi; Zhude Tu; Xuyi Yue; Xiang Zhang; Hongjun Jin; Joel S Perlmutter; Richard Laforest
Journal:  EJNMMI Res       Date:  2015-12-10       Impact factor: 3.138

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.